Hyperfine, Inc. (NASDAQ:HYPR) Short Interest Update

Hyperfine, Inc. (NASDAQ:HYPR) saw a significant decline in short interest in December. As of December 15th, there was short interest totaling 659,270 shares, a decline of 15.6% from the November 30th total of 780,752 shares. Currently, 1.0% of the shares of the stock are sold short. Based on an average daily volume of 894,142 shares, the days-to-cover ratio is currently 0.7 days. Based on an average daily volume of 894,142 shares, the days-to-cover ratio is currently 0.7 days. Currently, 1.0% of the shares of the stock are sold short.

Hyperfine Price Performance

HYPR stock opened at $0.98 on Friday. The business has a fifty day moving average price of $1.06 and a 200 day moving average price of $1.14. Hyperfine has a fifty-two week low of $0.53 and a fifty-two week high of $2.22. The stock has a market capitalization of $95.16 million, a price-to-earnings ratio of -1.88 and a beta of 1.09.

Hyperfine (NASDAQ:HYPR) last announced its earnings results on Thursday, November 13th. The company reported ($0.11) EPS for the quarter, missing the consensus estimate of ($0.10) by ($0.01). Hyperfine had a negative return on equity of 97.95% and a negative net margin of 378.17%.The business had revenue of $3.44 million for the quarter, compared to the consensus estimate of $3.51 million. On average, equities analysts expect that Hyperfine will post -0.57 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several research analysts have issued reports on the company. Wall Street Zen upgraded Hyperfine from a “sell” rating to a “hold” rating in a research note on Saturday, October 25th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Hyperfine in a report on Wednesday, October 8th. Two research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, Hyperfine presently has a consensus rating of “Hold” and an average target price of $1.28.

Hedge Funds Weigh In On Hyperfine

A number of large investors have recently modified their holdings of the stock. EP Wealth Advisors LLC bought a new stake in shares of Hyperfine during the first quarter valued at approximately $25,000. Tortoise Investment Management LLC acquired a new position in Hyperfine in the third quarter valued at approximately $65,000. Finally, Vanguard Group Inc. boosted its position in shares of Hyperfine by 5.7% in the 3rd quarter. Vanguard Group Inc. now owns 3,511,972 shares of the company’s stock worth $5,092,000 after purchasing an additional 190,136 shares during the last quarter. 15.03% of the stock is currently owned by institutional investors and hedge funds.

Hyperfine Company Profile

Hyperfine, Inc (NASDAQ: HYPR) is a medical technology company focused on expanding access to advanced neuroimaging through its portable magnetic resonance imaging (MRI) system. The company’s flagship product, Swoop®, is designed to enable bedside MRI scanning in a wide range of clinical environments, including emergency departments, intensive care units and outpatient clinics. By leveraging a compact, high-performance permanent magnet and a custom-designed gradient system, Hyperfine aims to reduce the logistical and financial barriers associated with traditional, large-scale MRI installations.

The Swoop system features a lightweight, wheeled design that can be maneuvered directly to a patient’s bedside, allowing clinicians to conduct diagnostic imaging without the need to transport critically ill or immobile patients.